Roschger P, Gupta HS, Berzlanovich A, Ittner G, Dempster DW, Fratzl P, Cosman F, Parisien M, Lindsay R, Nieves JW, Klaushofer K. Constant mineralization density distribution in cancellous human bone. Bone 32:316-323, 2003
Zhou H., Iida-Klein A., Lu S.S., Ducayen-Knowles
M, Levine LR, Dempster D.W., Lindsay R. Anabolic action of
PTH on cortical and cancellous bone differs between axial
and appendicular skeletal sites in mice. Bone 32:513-520,
2003
Misof B, Roschger P, Cosman F, Kurland ES,
Tesch W, Mebmer, P, Dempster DW, Nieves J, Shane E, Fratzl
P, Klaushofer K, Bilezikian J, Lindsay R Effects of intermittent
parathyroid hormone administration on bone mineralization
density in iliac crest biopsies from patients with osteoporosis:
a paired study before and after treatment. J Clin Endocrinol
Metab 88:1150-1156, 2003
Kim CH, Takai E, Zhou H, von Stechow D, Müller
R, Dempster DW, Guo XE Trabecular bone response to mechanical
and parathyroid hormone stimulation:The role of mechanical
microenvironments. J Bone Miner Res 18:2116-2125, 2003.
Dempster DW. Bone microarchitecture and strength. Osteoporos Int 14 (Suppl 5): S54-56, 2003
Dorai T, Dutcher JP, Dempster DW, Wiernik PH.
Therapeutic potential of curcumin in prostate cancer. IV:
Interference with the osteomimetic properties of hormone refractory
C4-2B prostate cancer cells. The Prostate 60:1-17, 2004
Dempster DW, Hughes-Begos C, Plavetic-Chee K, Brandao-Burch A, Cosman F, Nieves J, Neubort S, Lu S, Iida-Klein A, Arnett T, Lindsay R. Normal human osteoclasts formed from peripheral blood monocytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts, Journal of Cellular Biochemistry 95: 139-148, 2005.
Hodsman AB, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, Kendler D, McClung MR, Miller PD, Olszynski WP, Orwoll E, Yuen CK. Parathyroid hormone and teriparatide for the treatment of osteoporosis: A review of the evidence and suggested guidelines for its use. Endocrine Reviews 2005;26: 688-703
Donovan MA, Dempster DW, Zhou H, McMahon DJ, Fleischer J, Shane E. Low bone formation in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab. 2005 Jun;90(6):3331-6.
Iida-Klein A, Lu SS, Kapadia R, Burkhart M, Moreno A, Dempster DW, Lindsay R. Short-term continuous infusion of human parathyroid hormone 1-34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL/J6 mice. J Endocrinol. 2005; 186:549-57.
Lindsay R, Cosman F, Zhou H, Bostrom MP, Shen VW, Cruz J, Nieves J, Dempster DW. A novel tetracycline labeling schedule for longitudinal evaluation of the short term effects of anabolic therapy with a single biopsy: Early actions of teriparatide. J Bone Miner Res 2006; 21:366-373.
Kurihara N, Zhou H, Reddy S, Garcia Palacios V, Subler M, Dempster DW, Windle J, Roodman GD. Expression of measles virus nucleocapsid protein in osteoclasts induces Paget’s disease –like lesions in mice. J Bone Miner Res 2006; 21: 446-455.
Iida-Klein A, Hughes C, Shen V, Moreno A, Lu SS, Dempster DW, Cosman F, Lindsay R. Effects of cyclic vs. daily PTH regimens on bone strength in association with bone density, biochemical markers and bone structure in mice. J Bone Miner Res 2006;21: 274-282..
Dempster DW. Anatomy and functions of the adult skeleton. Primer on The Metabolic Bone Diseases and Disorders of Mineral Metaboism, Sixth Edition( Eds, M.J. Favus et al), The American Society for Bone and Mineral Research, 2006, pp 7-11
Dempster DW, Bolognese MA. Ibandronate: The evolution of a once-a-month oral therapy for postmenopausal osteoporosis. J Clin Densitometry 2006;9:58-65.
Kurland ES, Schulman RC, Zerwekh JE, Reinus WR, Dempster DW, Whyte MP. Recovery from skeletal fluorosis (an enigmatic, American case). In Press, JBMR
Roschger P, Dempster DW, Zhou H, Paschalis EP, Silverberg SJ, Bilezikian JP, Klaushofer K. Bone quality in mild primary hyperparathyroidism as determined by quantitative backscattered electron imaging. In Preparation.
Bauss F, Dempster DW.Effects of ibandronate on bone quality: preclinical studies. In press, Bone
Iida-Klein A, Lu SS, Cosman F, Lindsay R, Dempster DW. Effects of cyclic versus daily treatment with human parathyroid hormone (1-34) on bone structure and cellular activity. In Press, Bone.
|
